The title of this multiauthor volume is a little misleading. The contributions are based on the proceedings of the 31st annual symposium on the Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Cells. This was held in Indianopolis in October 1990 so the material is fairly topical. There are 24 papers covering a wide range of subjects. Not all of these have much connection with enzyme regulation, but a number will be of interest to cancer researchers. In particular there is quite a lot here for those interested in anticancer drug development. Space precludes mentioning all of the contributions, but some of these are discussed to give a flavour of the volume.
The chapter by Jackman et al. shows how an integration of enzymology with other investigations had led to the clinical evaluation of improved folate-based thymidylate synthetase inhibitors. Harrap and colleagues describe their progress in developing orally active platinum coordination complexes which also circumvent some forms of cisplatin resistance. The rationale for the combined inhibition of de novo and salvage pathways for purine and pyrimidine metabolism is reviewed by Weber et al.
I personally enjoyed the updates on the multiple forms of protein kinase C including their possible roles in cancer cell signalling (Ohno et al.) and on the regulation of the glutathione transferase P gene (Muramatsu et al.) and the CYPIAJ gene which encodes the cytochrome P450 lAl (Lusska et al.) .
The review by Estabrook et al. gives some nice samples of the value of expressing cloned P450 genes in bacterial, yeast or mammalian host cells. Schwab provides a critical piece on N-myc and Capitani and colleagues discuss their data on nuclear inositol lipids in the context of the growing realisation that the isoitol lipid -protein kinase C signalling pathways may exist within the nucleus itself. A major problem with both antibodies and antisense oligonucleotides as therapeutic agents concerns the delivery of these large molecules and Severin et al. show how 'hydrophobisation' with fatty acid residues may improve their antiviral activity.
Inevitably in this type of production there are stylistic disparities between contributions, some being pure reviews, but most being more formal presentations of in-house data. Also inevitably, most of the material has appeared or will appear elsewhere in the literature. I found some of 'Session' titles rather puzzling. The book is also expensive. However, the articles are readable and interesting and the quality of the editing and production is excellent. There should be something in this pot pourri to interest most cancer researchers (certainly most cancer pharmacologists). I for one found it worth perusing, not least for the charming and informative personal anecdote from Nobel Laureate George Hitchings which concludes the book. This is the second edition of Immunodiagnosis of Cancer, the 53rd publication in an immunology series going back more than a decade. Since the previous edition was published in 1979, there has been a vast expansion in immunological techniques including the widespread availability and use of monoclonal antibodies. In addition, the increasing sensitivity and specificity of assay procedures has lead to much greater complexity in this field. In this edition, the editors aim to acquaint the reader with both the theoretical and practical aspects of immunodiagnosis and its relevance in cancer. They cover experimental design, methodology, organ site-associated tumour markers and non organ site-restricted tumour markers.
The standard of contributions in this book is generally high. There is a concise overview of the value of serum markers in a number of common tumour types emphasising the uses (and limitations) of a panel approach. The methodology section reviews the majority of useful techniques in detail; as well as monoclonal antibodies (production and usage) and a full discussion of immunoassay technology, molecular biological techniques and flow cytometry are also covered. The organ site-associated tumour markers are reviewed in seventeen chapters, each devoted to a particular tumour site or type; much of this gives us interesting insight into the biology of these tumours. The immunophenotypic classification of lymphoma and leukaemia using a few crucial commercially available immunocytochemical markers, and the use of serum markers to assess response of certain tumours to treatment, are of particular practical value. The fourth section deals with topics such as immunoglobulins, acute phase proteins, immune complexes, fibronectin, serum isoenzymes, mucin glycoproteins and placental proteins. Each of these chapters gives an up to date statement of present knowledge with an extensive literature review.
The text is liberally sprinkled with high quality line drawings and tables where appropriate. The book highlights those areas in which there is uncertainty and suggests a wide area of potential expansion in the future. It must be regarded as a key reference text for both research workers and clinicians with an interest in tumour pathology and immunology. Surgical pathologists sometimes feel regarded by their clinical colleagues as a modern manifestation of the oracle of ancient times. Instead of sacrificing an animal and then examining its entrails to foretell the future we now remove part of the patient instead and then expect the pathologist to provide detailed prognostic information on the biopsy material that is submitted to the laboratory. Of course the ancient Greeks did not go to any old oracle, but would travel to Delphi for the best available opinion. In present times it is not always appreciated that the choice of surgical pathologist may be as important as the choice of oracle in those days, and can easily be as important as the choice of surgeon or oncologist in determining the changes of success in the diagnosis and management of patients with tumours. The experience of the British Melanoma Club over the last decade has shown clearly that in the field of pigmented lesions there is considerable interobserver variation, with universal agreement on diagnosis hard to find amongst a group of motivated and
